Novavax (NVAX) Stock
Novavax (NVAX) closed at $8.53 on Nov 13, 2026; its Tenet Score is 58 of 100 against 409 Healthcare peers.
27 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $8.53
- Nov 13, 2026
- Market cap
- $1.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 6.20 – 13.38
- low → high
- Tenet Score
- 58/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Novavax, Inc. scores 58/100. Mixed. Strongest on value, quality is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Graham Defensive
- ~ Income & Dividend Safety
- ✕ Quality Compounder
13F flows & insider trades land here.
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine can…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| NanobiotixNBTX | 37 | $1.5B |
| Pacira BioSciences IncPCRX | 55 | $1.5B |
| Absci CorpABSI | 37 | $1.5B |
| Korsana Biosciences Inc.KRSA | 41 | $1.4B |
| AnaptysBio IncANAB | 50 | $1.4B |
| Ocular Therapeutix IncOCUL | 53 | $1.4B |
| Intellia Therapeutics IncNTLA | 43 | $1.4B |
| Mineralys Therapeutics IncMLYS | 55 | $1.4B |
| Innoviva IncINVA | 74 | $1.4B |
| Taysha Gene Therapies IncTSHA | 59 | $1.3B |
Compare Novavax with
Common questions
What sector and industry is Novavax in?
Novavax is in the Healthcare sector and the Drugs industry.
What is Novavax's Tenet Score?
Novavax's Tenet Score is 58 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




